ERK Inhibitor LY3214996 Targets ERK Pathway-Driven Cancers: A Therapeutic Approach Toward Precision Medicine

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-19-0183
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

A Compendium of ERK Targets

FEBS Letters
GeneticsCell BiologyMolecular BiologyBiochemistryStructural BiologyBiophysics
2017English

SHOC2 Complex-Driven RAF Dimerization Selectively Contributes to ERK Pathway Dynamics

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2019English

A Genomic Approach to Active Surveillance: A Step Toward Precision Medicine

Asian Journal of Andrology
MedicineUrology
2013English

Combination of a Selective HSP90α/β Inhibitor and a RAS-RAF-MEK-ERK Signaling Pathway Inhibitor Triggers Synergistic Cytotoxicity in Multiple Myeloma Cells

PLoS ONE
Multidisciplinary
2015English

The NO-cGMP-PKG Signaling Pathway Coordinately Regulates ERK and ERK-Driven Gene Expression at Pre- And Postsynaptic Sites Following LTP-Inducing Stimulation of Thalamo-Amygdala Synapses

Neural Plasticity
Neurology
2010English

The ERK MAPK Pathway in Bone and Cartilage Formation

2012English

Simalikalactone E (SkE), a New Weapon in the Armamentarium of Drugs Targeting Cancers That Exhibit Constitutive Activation of the ERK Pathway

Oncotarget
Oncology
2012English

Genotypes and Phenotypes: Making Progress Toward a Precision Medicine Approach in Pediatric Pulmonary Hypertension

Advances in Pulmonary Hypertension
2018English

A YWHAZ Variant Associated With Cardiofaciocutaneous Syndrome Activates the RAF-ERK Pathway

Frontiers in Physiology
Physiology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy